evidence with checkpoint inhibition in hcc
Published 7 years ago • 473 plays • Length 7:10Download video MP4
Download video MP3
Similar videos
-
6:03
two options for checkpoint inhibition in hcc
-
1:10
the impact of immunotherapy and checkpoint inhibition in treating hcc
-
1:36
checkmate 9dw: the future of checkpoint inhibitors in advanced hcc
-
1:36
cabozantinib in patients with hcc refractory to checkpoint inhibitors
-
5:03
opportunities for checkpoint inhibitors in advanced hcc
-
20:45
ct scan liver normal vs hepatocellular carcinoma (hcc) images | liver cancer imaging diagnoses
-
1:02:49
pd-l1/pd-1 cancer immunotherapy and new targets - gordon freeman, phd
-
1:35:10
mapping the optimal treatment route in hcc: best practices
-
7:16
anticipating results of checkpoint inhibitors in hcc
-
2:07
immune checkpoint inhibitors, the next generation cancer therapy - creative biolabs
-
7:35
checkpoint inhibitors versus tki therapy in hcc
-
14:37
how to integrate new agents in hcc: the role of checkpoint inhibitors
-
5:20
nivolumab and checkpoint inhibitors in hcc
-
4:53
checkpoint inhibition in hepatocellular carcinoma
-
3:30
optimizing checkpoint inhibitor combinations in hcc
-
1:37:24
evidence-based treatment selection and sequencing in advanced hcc
-
24:30
controversies in hepatology: checkpoint inhibitors as first line therapy in hcc
-
2:04
synergy of anti-androgenic agents and immune checkpoint inhibitors in hcc
-
9:27
implications for i/o therapy in the treatment of hcc
-
1:57
dr. pinato on pd-l1 testing in hcc
-
37:10
immune checkpoint inhibitor in hepatocellular carcinoma
-
6:26
developing checkpoint inhibition in genitourinary cancers